Edit |   |
---|---|
Antigenic Specificity | EPCAM/CD326 (Tucotuzumab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | IgG1-ND |
Format | Protein A/G purified |
Size | 100 µg, 1 mg, |
Concentration | typically between 0.5-2.0 mg/ml. |
Applications | ELISA, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Tucotuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting EPCAM/CD326, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Tucotuzumab celmoleukin is under investigation in clinical trial NCT00016237 (Interleukin-2 Combined With monoclonal antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment). |
Immunogen | n/a |
Other Names | Tucotuzumab, EPCAM/CD326, 339986-90-2 |
Gene, Accession # | CAS: 339986-90-2 |
Catalog # | abx831138 |
Price | please inquire |
Order / More Info | EPCAM/CD326 (Tucotuzumab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950